BIBLIOGRAFIA
1. Hiroshi Maeda (Theme Editor), Advanced Drug Delivery Reviews, 61, (2009) 285-286
2. M. Takahashi, T. Nagai, N. Okamura, H. Takahashi, A.
Okano, Biol. Reprod. 66 (2002) 562–567.
3. J. Yoshitake, T. Akaike, T. Akuta, F. Tamura, T. Ogura, H.
Esumi, H. Maeda, J. Virol. 78 (2004) 8709–8719.
4. K. Sato, T. Akaike, M. Kohno, M. Ando, H. Maeda, J. Biol.
Chem. 267 (1992) 25371–25377.
5. Keiichiro Suzuki, Advanced Drug Delivery Reviews, 61 (2009) 287-289.
6 Jun Fang, Takahiro Seki, Hiroshi Maeda, Advanced Drug Delivery Reviews, (2009) 290-302.
7 Yoshii Y, Furukawa T, Yoshii H, Mori T, Kiyono Y, Waki A, Kobayashi M, Tsujikawa T, Kudo T, Okazawa H, Yonekura Y, Fujibayashi Y, Cancer Sci. 2009 May;100(5):821-7.
8 Mitscher, L. A., Jung, M., Shankel, D., Dou, J. H., Steele, L.,
& Pillai, S. P., (1997), Med Res Rev, 17(4), 327-365.
9 Ames, B. N. (1983), Science, 221(4617), 1256-1264.
10 T. Akaike, S. Okamoto, T. Sawa, J. Yoshitake, F. Tamura, K.
Ichimori, K. Miyazaki, K. Sasamoto, H. Maeda, Proc. Natl.
Acad. Sci. U. S. A. 100 (2003) 685–690.
11 T. Akaike, H. Maeda, Pathophysiological effects of high- output production of nitric oxide, in: L.J. Ignarro (Ed.), Nitric Oxide: Biology and Pathobiology, Academic Press, San Diego, 2000, pp. 733–745.
12 T. Sawa, M.H. Zaki, T. Okamoto, T. Akuta, Y. Tokutomi, S.
Kim-Mitsuyama, H. Ihara, A. Kobayashi, M. Yamamoto, S.
Fujii, H. Arimoto, T. Akaike, Protein S-guanylation by the biological signal 8-nitroguanosine 3′,5′-cyclic monophosphate, Nat. Chem. Biol. 3 (2007) 727–735.
13 Takaaki Akaike, Shigemoto Fujii, Tomohiro Sawa, Hideshi Ihara, Cell signaling mediated by nitrated cyclic guanine nucleotide, Nitric Oxide 23 (2010) 166–174.
14 Edaravone Acute Infarction Study Group, Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain
infarction. Randomized, placebo-controlled,double-blind study at multicenters, Cerebrovasc. Dis. 15 (2003) 222–229.
15 K.M. Channon, T.J. Guzik, Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors, J. Physiol.
Pharmacol. 53 (2002) 515–524.
16 Jun Fang, Arun K. Iyer, Takahiro Seki, Hideaki Nakamura, Khaled Greish , Hiroshi Maeda, SMA–copolymer conjugate of AHPP: A polymeric inhibitor of xanthine oxidase with potential antihypertensive effect, Journal of Controlled Release 135 (2009) 211–217.
17 K. Kakimoto, Y. Kojima, K. Ishii, K. Onoue, H. Maeda, The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice, Clin. Exp. Immunol. 94 (1993) 241–246.
18 R. Igarashi, J. Hoshino, M. Takenaga, S. Kawai, Y. Morizawa, A. Yasuda, M. Otani, Y. Mizushima, Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance, J. Pharmacol. Exp. Ther. 262 (1992) 1214–1219.
19 Y Suzuki, T Matsumoto, S Okamoto, and T Hibi, A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis, Colorectal Dis. 2008 November; 10(9):
931–934.
b) Ken-Ichiro Tanaka, Tomoaki Ishihara, Arata Azuma, Shoji Kudoh, Masahito Ebina, Toshihiro Nukiwa, Yukihiko Sugiyama, Yuichi Tasaka, Takushi Namba, Tsutomu Ishihara, Keizo Sato, Yutaka Mizushima, and Tohru Mizushima, Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol 298: L348–L360, 2010.
c) Ishihara T, Tanaka K, Tasaka Y, Namba T, Suzuki J, Ishihara T, Okamoto S, Hibi T, Takenaga M, Igarashi R, Sato K, Mizushima Y, Mizushima T., Therapeutic effect of lecithinized superoxide dismutase against colitis, J Pharmacol Exp Ther. 2009 Jan; 328(1):152-64.
20 Gozzelino R, Jeney V, Soares MP, Mechanisms of cell protection by heme oxygenase-1, Annu Rev Pharmacol Toxicol. 2010; 50:323-54.
21 Y. Ishima, T. Sawa,U. Kragh-Hansen, Y.Miyamoto, S.Matsushita, T. Akaike,M. Otagiri, S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial
and cytoprotective properties, J. Pharmacol. Exp. Ther. 320 (2007), 969–977.
22 D. Wakamatu, S. Morimura, T. Sawa, K. Kida, C. Nakai, H.
Maeda, Isolation, identification, and structure of a potent alkyl–peroxyl radical scavenger in crude canola oil, canolol, Biosci. Biotechnol. Biochem. 69 (2005) 1568–1574.
23 X. Cao, T. Tsukamoto, T. Seki, H. Tanaka, S. Morimura, L.
Cao, T. Mizoshita, H. Ban, T. Toyoda, H. Maeda, M.
Tatematsu, 4-Vinyl-2,6-dimethoxyphenol (canolol) suppresses oxidative stress and gastric carcinogenesis in Helicobacter pylori-infected carcinogen-treated Mongolian gerbils, Int. J. Cancer 122 (2008) 1445–1454.
24 a) Y.J. Surh, Cancer chemoprevention with dietary phytochemicals, Nat. Rev. Cancer 3 (2003) 768–780.
b) Ramos S., Cancer chemoprevention and chemotherapy:
dietary polyphenols and signalling pathways, Mol Nutr Food Res. 2008 May;52(5):507-26.
25 J. Fang, H. Nakamura, D.W. Deng, T. Akuta, K. Greish, A.K.
Iyer, H. Maeda, Oxystress inducing antitumor therapeutics via targeted delivery of PEG-conjugated D-aminoacid oxidase, Int. J. Cancer 122 (2008) 1135–1144.
26 Regehly M, Greish K, Rancan F, Maeda H, Böhm F, Röder B., Water-soluble polymer conjugates of ZnPP for photodynamic tumor therapy, Bioconjug Chem. 2007 Mar- Apr;18(2):494-9.
27 J. Fang, T. Sawa, T. Akaike, K. Greish, H. Maeda, Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin, Int. J. Cancer 109 (2004) 1–8.
28 R. Kondo, K.V. Gleixner, M. Mayerhofer, A. Vales, A.
Gruze, P. Samorapoompichit, K. Greish, M.T. Krauth, K.J.
Aichberger, W.F. Pickl, H. Esterbauer, C. Sillaber, H. Maeda, P. Valent, Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells, Blood 110 (2007) 661–669.
29 E. Hadzijusufovic, L. Rebuzzi, K.V. Gleixner, V. Ferenc, B.
Peter, R. Kondo, A. Gruze, M. Kneidinger, M.T. Krauth, M.
Mayerhofer, P. Samorapoompichit, K. Greish, A.K. Iyer, W.F. Pickl, H. Maeda, M. Willmann, P. Valent, Targeting of heat-shock protein 32/heme oxygenase-1 in canine
mastocytoma cells is associated with reduced growth and induction of apoptosis, Exp. Hematol. 36 (2008) 1461–1470.
30 M. Murakami, T. Hirano, Intracellular zinc homeostasis and zinc signaling, Cancer Sci. 99 (2008) 1515–1522.
31 Bernadett Kalmar, Linda Greensmith, Advanced Drug Delivery Reviews 61 (2009) 310–318.
32 M.P. Mayer, B. Bukau, Hsp70 chaperones: cellular functions and molecular mechanism, Cell. Mol. Life Sci. 62 (2005) 670–
684.
33 M. Joyeux-Faure, C. Arnaud, D. Godin-Ribuot, C. Ribuot, Heat stress preconditioning and delayedmyocardial protection:what is new? Cardiovasc. Res. 60 (2003) 469–477.
34 D.K. Das, N. Maulik, Cardiac genomic response following preconditioning stimulus, Cardiovasc. Res. 70 (2006) 254–
263.
35 T. Olsson, O. Hansson, J. Nylandsted, M. Jaattela, M.L.
Smith, T. Wieloch, Lack of neuroprotection by heat shock protein 70 overexpression in a mouse model of global cerebral ischemia, Exp. Brain Res. 154 (2004) 442–449.
36 W.L. van der, M.F. Lythgoe, R.A. Badin, L.M. Valentim, M.T. Akbar, J.S. de Belleroche, D.S. Latchman, D.G. Gadian, Neuroprotective effects of HSP70 overexpression after cerebral ischaemia—an MRI study, Exp. Neurol. 195 (2005) 257–266.
37 R.C. Cumming, N.L. Andon, P.A. Haynes, M. Park,W.H.
Fischer, D. Schubert, Protein disulfide bond formation in the cytoplasm during oxidative stress, J. Biol. Chem. 279 (2004) 21749–21758.
38 M.W. Musch, A. Kapil, E.B. Chang, Heat shock protein 72 binds and protects dihydrofolate reductase against oxidative injury, Biochem. Biophys. Res. Commun. 313 (2004) 185–
192.
39 V. Calabrese, A.M. Stella, D.A. Butterfield, G. Scapagnini, Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance, Antioxid. Redox. Signal. 6 (2004) 895–913.
40 M. Ilbert, J. Horst, S. Ahrens, J. Winter, P.C. Graf, H. Lilie, U. Jakob, The redox-switchdomain of Hsp33 functions as dual stress sensor, Nat. Struct. Mol. Biol. 14 (2007) 556–563.
41 A. Gorlach, Redox control of blood coagulation, Antioxid.
Redox. Signal. 6 (2004)687–690.
42 J.D. Malhotra, R.J. Kaufman, Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?
Antioxid. Redox. Signal. 9 (2007) 2277–2293.
43 C. Soti, E. Nagy, Z. Giricz, L. Vigh, P. Csermely, P.
Ferdinandy, Heat shock proteins as emerging therapeutic targets, Br. J. Pharmacol. 146 (2005) 769–7 80.
44 J. Fang, T. Sawa, T. Akaike, H. Maeda, Tumor-targeted delivery of polyethyleneglycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide, Cancer Res. 62 (2002) 3138–3143.
45 R. Kondo, K.V. Gleixner, M. Mayerhofer, A. Vales, A.
Gruze, P. Samorapoompichit, K. Greish,M.T. Krauth, K.J.
Aichberger,W.F. Pickl, H. Esterbauer, C. Sillaber, H.Maeda, P. Valent, Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells, Blood 110 (2007) 661–669.
46 M. Mayerhofer, K.V. Gleixner, J. Mayerhofer, G. Hoermann, E. Jaeger, K.J. Aichberger,R.G. Ott, K. Greish, H. Nakamura, S. Derdak, P. Samorapoompichit, W.F. Pickl, V. Sexl, H.
Esterbauer, I. Schwarzinger, C. Sillaber, H. Maeda, P. Valent, Targeting of heat shock protein 32 (Hsp32)/heme oxygenase- 1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib, Blood 111 (2008) 2200–2210.
47 Carol A. Ballinger, Patrice Connell, Yaxu Wu, Zhaoyong Hu, Larry J. Thompson, Li-Yan Yin, and Cam Patterson, Identification of CHIP, a Novel Tetratricopeptide Repeat- Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions, Mol Cell Biol. 19 (1999) 4535–4545.
48 S. Murata, T. Chiba, K. Tanaka, CHIP: a quality-control E3 ligase collaborating with molecular chaperones, Int. J.
Biochem. Cell Biol. 35 (2003) 572–578.
49 M.F. Rosser, E. Washburn, P.J. Muchowski, C. Patterson, D.M. Cyr, Chaperone functions of the E3 Ubiquitin ligase, CHIP J. Biol. Chem. 282 (31) (2007) 22267–22277.
50 A.P. Arrigo, S. Virot, S. Chaufour,W. Firdaus, C. Kretz- Remy, C. Diaz-Latoud, Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced
form and by decreasing iron intracellular levels, Antioxid.
Redox. Signal. 7 (2005) 414–422.
51 A.P. Arrigo, The cellular “networking” ofmammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis, Adv. Exp.Med. Biol. 594 (2007) 14–26.
52 S. Kaushik, R. Kiffin, A.M. Cuervo, Chaperone-mediated autophagy and aging: a novel regulatory role of lipids revealed, Autophagy 3 (2007) 387–389.
53 S. Kaushik, A.M. Cuervo, Chaperone-mediated autophagy methods, Mol. Biol. 445 (2008) 227–244.
54 S.L. Mehta, N. Manhas, R. Raghubir, Molecular targets in cerebral ischemia for developing novel therapeutics, Brain Res. Rev. 54 (2007) 34–66.
69.(55) N. Vanlangenakker, T.V. Berghe, D.V. Krysko,N.
Festjens, P. Vandenabeele,Molecular mechanisms and pathophysiology of necrotic cell death, Curr. Mol. Med. 8 (2008) 207–220.
56 Makiya Nishikawa, Mitsuru Hashida, Yoshinobu Takakura, Advanced Drug Delivery Reviews 61 (2009) 319–326
57 O. Loew, A new enzyme of general occurrence in organisms, Science 11 (1900) 701–702.
58 J.M. McCord, I. Fridovich, Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), J. Biol.
Chem. 244 (1969) 6049–6055.
59 Henry N. Kirkman1, and Gian F. Gaetani, Trends in Biochemical Sciences Volume 32, Issue 1, January 2007, Pages 44-50
60 D. Andrés, I. Sánchez-Reus, M. Bautista, M. Cascales, Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity. Expression of metallothionein and HSP70, Biochem. Pharmacol. 66 (2003) 917–926.
61 K. Uchikura, T. Wada, S. Hoshino, Y. Nagakawa, T. Aiko, G.B. Bulkley, A.S. Klein, Z. Sun, Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species, Am. J.
Physiol. 287 (2004) G620–G626.
62 S.F. Ma, M. Nishikawa, H. Katsumi, F. Yamashita, M.
Hashida, Liver targeting of catalase by cationization for
prevention of acute liver failure in mice, J. Control. Release 110 (2006) 273–282
63 V.M. Gonzalez, M.A. Fuertes, C. Alonso, J.M. Perez, Is cisplatin-induced cell death always produced by apoptosis?
Mol. Pharmacol. 59 (2001) 657–663.
64 Y. Kobayashi, M. Nishikawa, K. Hyoudou, F. Yamashita, M.
Hashida, Hydrogen peroxide-mediated nuclear factor κB activation in both liver and tumor cells during initial stages of hepatic metastasis, Cancer Sci. 99 (2008) 1546–1552.
65 P. Storz, Reactive oxygen species in tumor progression, Front. Biosci. 10 (2005) 1881–1896.
66 K. Hyoudou, M. Nishikawa, Y. Kobayashi, Y. Umeyama, F.
Yamashita, M. Hashida, PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal, Free Radic. Biol. Med. 41 (2006) 1449–1458.
